
How India can become ‘Aatma Nirbhar’ and become a global hub for the Pharma sector?
Manipal ProLearn School of Pharma, in
association with ObserveNow Media, is organising a Pharma Leaders virtual
conference on 21st August at 4:00 PM to 5:30 PM, IST on ‘Emerging Skills in Indian
Pharma and Ways to bridge the Skill-gap’.
The idea behind the virtual conference is to understand how Indian Pharma sector needs to prepare itself for addressing both the opportunity and the challenge in becoming the global hub for production of not just generics and APIs but branded pharma products as well, to become “Aatma Nirbhar’ in the pharmaceutical industry. Understanding the challenges we face to beat our competitor China to become the self-reliant in APIs and the global hub of production.
A special initiative by Manipal ProLearn
School of Pharma will also focus on how can organisations like Manipal School of Pharma play a critical role
in bridging this gap. The expert panel will decode and deliberate on how to
scale up Indian pharmaceutical companies – while the Indian pharma
industry has a history of having collaborated with global MNCs to expand global
supplies of critical medicines and are continually cooperating on vaccine
development, but home-grown Indian pharma companies have yet to make it to the
list of Top 30 Global Pharma Companies (by turnover) – why are Indian pharma
companies not being able to become global conglomerates of that scale.
The Indian pharma sector is worth almost USD
55 billion, and the biotech sector will touch USD 100 billion by 2025. The
experts will discuss how best we could leverage this market for India to shine
in the pharma sector.
The panellists for this session are :
- Mr Subrat
Mohanty, Group President, Manipal Education & Manipal Group (MEMG)
- Mr Chandru
Chawla, Executive VP - US Speciality (Respiratory), Board member of
Cipla Health, Cipla Limited
- Mr Farhat Umar,
Sr VP- Group HR Head, Mankind Pharma
- Mr Ajay Bhatt,
President Global HR, Intas Pharma
- Mr. Suresh
Sugavanam, Vice President and MD, South Asia and Sub-Saharan Africa, UL
{{getArticleReviewList.length}} Comments

{{item.FirstName}} {{item.LastName}}
{{item.LastActivityOn | date:'dd MMM, yyyy hh:mm:ss a'}}
{{item.Description}}